How to buy Geron Corporation stock - 08 March

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Geron Corporation stock

Own Geron Corporation stock in just a few minutes.


Fact checked

Geron Corporation is a biotechnology business based in the US. Geron Corporation shares (GERN) are listed on the NASDAQ and all prices are listed in US Dollars. Geron Corporation employs 45 staff and has a trailing 12-month revenue of around USD$374,000.

How to buy shares in Geron Corporation

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Geron Corporation. Find the stock by name or ticker symbol: GERN. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Geron Corporation reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Geron Corporation, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Geron Corporation. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Geron Corporation share price

Use our graph to track the performance of GERN stocks over time.

Geron Corporation shares at a glance

Information last updated 2021-03-03.
52-week rangeUSD$0.83 - USD$2.36
50-day moving average USD$1.8535
200-day moving average USD$1.8208
Wall St. target priceUSD$4
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.2

Buy Geron Corporation shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Gold/Commodities
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stocks, Options, ETFs
Get two free stock valued between $2.50 and $250
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Stocks, Options, Cryptocurrency
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
Get 100 shares of stock (worth $1 to $6 a share)
Open and fund a new cash or margin account with $2,000+
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Interactive Brokers
Stocks, Bonds, Options
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Geron Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Geron Corporation financials

Revenue TTM USD$374,000
Gross profit TTM USD$-38,803,000
Return on assets TTM -23.24%
Return on equity TTM -42%
Profit margin 0%
Book value $0.75
Market capitalisation USD$541.8 million

TTM: trailing 12 months

Shorting Geron Corporation shares

There are currently 36.4 million Geron Corporation shares held short by investors – that's known as Geron Corporation's "short interest". This figure is 1.6% down from 37.0 million last month.

There are a few different ways that this level of interest in shorting Geron Corporation shares can be evaluated.

Geron Corporation's "short interest ratio" (SIR)

Geron Corporation's "short interest ratio" (SIR) is the quantity of Geron Corporation shares currently shorted divided by the average quantity of Geron Corporation shares traded daily (recently around 4.2 million). Geron Corporation's SIR currently stands at 8.65. In other words for every 100,000 Geron Corporation shares traded daily on the market, roughly 8650 shares are currently held short.

However Geron Corporation's short interest can also be evaluated against the total number of Geron Corporation shares, or, against the total number of tradable Geron Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Geron Corporation's short interest could be expressed as 0.12% of the outstanding shares (for every 100,000 Geron Corporation shares in existence, roughly 120 shares are currently held short) or 0.1178% of the tradable shares (for every 100,000 tradable Geron Corporation shares, roughly 118 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Geron Corporation.

Find out more about how you can short Geron Corporation stock.

Geron Corporation share dividends

We're not expecting Geron Corporation to pay a dividend over the next 12 months.

Have Geron Corporation's shares ever split?

Geron Corporation's shares were split on a 1058:1000 basis on 22 July 2014. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1058 shares. This wouldn't directly have changed the overall worth of your Geron Corporation shares – just the quantity. However, indirectly, the new 5.5% lower share price could have impacted the market appetite for Geron Corporation shares which in turn could have impacted Geron Corporation's share price.

Geron Corporation share price volatility

Over the last 12 months, Geron Corporation's shares have ranged in value from as little as $0.83 up to $2.36. A popular way to gauge a stock's volatility is its "beta".

GERN.US volatility(beta: 1.27)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Geron Corporation's is 1.2743. This would suggest that Geron Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Geron Corporation overview

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for hematologic myeloid malignancies. It holds rights to imetelstat, a telomerase inhibitor in Phase 2/3 clinical trials, which inhibits the uncontrolled proliferation of malignant progenitor cells in hematologic myeloid malignancies to reduce dysfunctional blood cell production and enable recovery of normal blood cell production. The company was founded in 1990 and is headquartered in Menlo Park, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site